39 research outputs found

    Characteristics of the different cut-off values on the IHDS.

    No full text
    <p>Characteristics of the different cut-off values on the IHDS.</p

    Correlation of the IHDS and a) TMT Part B and b) Digit Span Backwards subtests; and correlation of the HAND diagnostic subtype and c) TMT Part B and d) d2 Concentration subtests.

    No full text
    <p>Correlation of the IHDS and a) TMT Part B and b) Digit Span Backwards subtests; and correlation of the HAND diagnostic subtype and c) TMT Part B and d) d2 Concentration subtests.</p

    Number of cases of HAND and its subtypes in each study group.

    No full text
    <p>Number of cases of HAND and its subtypes in each study group.</p

    Group characteristics, scores obtained in the Int. HIV Dementia Scale (IHDS) and answers given in DNAA Questionnaire (sorted by study group).

    No full text
    <p>Group characteristics, scores obtained in the Int. HIV Dementia Scale (IHDS) and answers given in DNAA Questionnaire <u>(sorted by study group)</u>.</p

    CCR5Δ32 genotype distribution in HIV-positive and HIV-negative study subjects

    No full text
    1<p>2×2 or 3×2 χ2 comparisons, depending on the presence or absence of heterozygous and mutant homozygotes in the respective subgroup. Comparisons were conducted separately according to ethnicity</p

    Relation of CCR5Δ32 genotype with viral setpoints in 319 Caucasian seroconverters.

    No full text
    <p>Scattered dots represent individual viral setpoints (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0002747#s4" target="_blank">Material and Methods</a> for a definition), whereas vertical lines demarcate the median in each genetic group.</p

    Clinical, immunological and viral load characteristics in an HIV-infected patient homozygous for the CCR5Δ32 deletion (patient#12).

    No full text
    <p>Antiretroviral therapy was initiated twice, eight days after diagnosis with efavirenz (EFV), stavudine (d4T) and lopinavir-ritonavir (LPVr) and again, following rapid disease progression, 18 months after diagnosis with Efavirenz and Zidovudine (AZT) plus Lamivudine (3TC). Unbroken line with closed circles: CD4<sup>+</sup> T-cell counts. Unbroken line with closed diamonds: Plasma viral loads. Broken line with closed circles: CD8<sup>+</sup> T-cell counts. Blue arrow: negative HIV-1 antibody test. Red arrow: positive HIV-1 antibody test. Black arrows: Proctitis (1) / Shigellosis (2).</p

    Demographic characteristics of HIV positive and HIV negative studied subjects

    No full text
    1<p>Age median (IR, interquantile range) in years.</p>2<p>Of these, n = 2 individuals were occupationally exposed to HIV; risk group is unknown for n = 14 individuals.</p
    corecore